A comparison of concurrent cisplatin versus cetuximab with radiotherapy in locally-advanced head and neck cancer: A bi-institutional analysis.

Stokes, William A; Sumner, Whitney A; Breggren, Kiersten L; Rathbun, John T; Raben, David; McDermott, Jessica D; Gan, Gregory; Karam, Sana D

Stokes, William A; Sumner, Whitney A; Breggren, Kiersten L; Rathbun, John T; Raben, David; McDermott, Jessica D; Gan, Gregory; Karam, Sana D.

Afiliación

Stokes WA; Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO, USA.
Sumner WA; Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO, USA.
Breggren KL; Department of Internal Medicine, Section of Radiation Oncology, University of New Mexico School of Medicine, Albuquerque, NM, USA.
Rathbun JT; Department of Internal Medicine, Section of Radiation Oncology, University of New Mexico School of Medicine, Albuquerque, NM, USA.
Raben D; Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO, USA.
McDermott JD; Division of Medical Oncology, Department of Medicine, University of Colorado School of Medicine, Aurora, USA.
Gan G; Department of Internal Medicine, Section of Radiation Oncology, University of New Mexico School of Medicine, Albuquerque, NM, USA.
Karam SD; Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, CO, USA.

Rep Pract Oncol Radiother ; 22(5): 389-395, 2017.

Article en En | MEDLINE | ID: mdl-28808428

Palabras clave

Cetuximab; Chemoradiotherapy; Cisplatin; Head and neck cancer; Radiosensitization

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Rep Pract Oncol Radiother Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google